Home
Adma Biologics

Adma Biologics Market Share Analysis for July 2026

ADMA Biologics, Inc., , engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Finance > Investing

Domainadmabiologics.com

Year Founded2004

Employees501 - 1000

Annual Revenue$500M - $1B

Adma Biologics

Adma Biologics (including company regionals)

admabiologics.com

See more website traffic and engagement information

Adma Biologics Revenue up to July 2026 is 500M - 1B

revenue generated by Adma Biologics top domains

Adma Biologics top domains revenue over 3 years

Revenue for Adma Biologics top domains

admabiologics.com500M - 1B

See more with Sales Intelligence

Total visits to Adma Biologics's top domains

Understand Adma Biologics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

admabiologics.com14.9K

See more with Sales Intelligence

Avg. visit duration in Adma Biologics's top domains

Analyze Adma Biologics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

admabiologics.com00:00:37

See more with Sales Intelligence

Avg. pageviews on Adma Biologics's top domains

See how Adma Biologics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

admabiologics.com5.33

See more with Sales Intelligence

Adma Biologics top competitors by domain

Top similar sites in July 2026, ranked by their affinity

iginnovate.comCompany NameIchnos Glenmark InnovationEmployees51 - 200HQUnited States, New York, New YorkAnnual revenue--Total visits3.1KN/A

Top technologies used by Adma Biologics

These are the website technologies, by industry, used by Adma Biologics top domains

Payment & Currencies (7)

Cart Functionality

Audio Video Media (4)

Vimeo

Advertising (3)

DoubleClick

Content Management System (3)

Web Dot Com

More Technologies

9

See all

News & Signals from Adma Biologics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsADMA Biologics, Inc. had issues with potential breaches of fiduciary duty on Aug 17th '26.PHILADELPHIA, Aug. 17, 2026 /PRNewswire/ - National plaintiffs' law firm Berger Montague PC announces an investigation into potential breaches of fiduciary duty by the Board of Directors of ADMA Biologics, Inc. (NASDAQ: ADMA) ("ADMA" or the "Company").

NewsHagens Berman Sobol Shapiro LLP filed suit against ADMA Biologics, Inc. on Aug 9th '26.SAN FRANCISCO, Aug. 9, 2026 /PRNewswire/ - Hagens Berman alerts investors in ADMA Biologics, Inc. (NASDAQ: ADMA) that a securities fraud class action lawsuit has been filed.

NewsPomerantz LLP filed suit against ADMA Biologics, Inc. on Aug 6th '26.NEW YORK, Aug. 6, 2026 /PRNewswire/ - Pomerantz LLP announces that a class action lawsuit has been filed against ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ: ADMA).